NCT00967148 - Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Deep Vein ThrombosisPulmonary EmbolismCancer

Interventions

DRUG

Tinzaparin

The treatment arm will receive a subcutaneous injection of tinzaparin (4500U) daily beginning within two days of the decision to operate (within 6 weeks of surgical resection) weeks and continued for 4 weeks following resection.

Trial Locations (1)

K1H 8L6

Ottawa Health Research Institute, Ottawa